UTSW & the Move to Patient-Centricity-based Clinical Trials in the Age of COVID-19
COVID-19 has led to a wave of new rules and a new set of expectations involving clinical trials as research […]
UT Southwestern Testing Favipiravir, Colchicine & Monoclonal Antibodies to Find Treatments for Mild to Moderate COVID-19 Cases
UT Southwestern Medical Center researchers are investigating existing, available drugs that could potentially help treat mild to moderate COVID-19 cases. […]
UT Southwestern on the Move in the Battle Against COVID-19
UT Southwestern is on the move, taking on COVID-19 in a number of ways. Recently, Dallas Innovates showcased five core […]
UT Southwestern Preclinical Research Points to Atovaquone as Possible COVID-19 Treatment
University of Texas Southwestern Medical Center researchers have identified a potential COVID-19 treatment in preclinical research activity targeting COVID-19, and […]
UT Southwestern Spinoff Comes out of Stealth Mode with a $30 Million Seed Round for Gene Therapy Platform
Taysha Gene Therapies just emerged out of stealth mode with a $30 million seed round and a strategic partnership with UT […]
UT Southwestern Study Team Applies QM & Six Sigma Principles to Streamline and Improve Clinical Trial Activation Times
Because delays or lags in the time it takes a clinical investigational site to activate a clinical trial can have […]
UT Southwestern Inks Deal to Collaborate to Ultimately Master ‘Exotransplantation’ for Regenerative Medicine Research
University of Texas Southwestern (UTSW) inked a collaborative research deal with Recombinetics (RCI) to identify key factors that improve the […]
How Cancer Cells Stiff-Arm Normal Environmental Cues to Consume Energy
Using human lung cancer cells, UT Southwestern researchers have uncovered how cells in general modulate their energy consumption based on […]
UT Southwestern Leads Study Demonstrating Neratinib & Everolimus Combo Halts Growth of Cancer Cells with HER2 Mutations
UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combination that halts the growth of cancer cells that carry […]
Time to Increase Patient Participation in Cancer Trials: From ‘Boiler Plate’ to Patient-Centric Paradigm
Federal regulations could be getting in the way of life and death as cancer patients in dire need of help […]
